nifedipine has been researched along with Arrhythmias, Cardiac in 157 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double-blind placebo-controlled trial to study the effect of nifedipine on ventricular arrhythmias among patients with acute myocardial infarction, 434 patients with suspected myocardial infarction were randomized within 6 h from the onset of chest pain to treatment with nifedipine (p = 217) or placebo (p = 217)." | 9.06 | Effect of nifedipine on arrhythmias in the acute phase of myocardial infarction. ( Adgey, AA; MacKenzie, G; Walker, LJ, 1988) |
| "In patients with coronary disease, the use of short-acting nifedipine in moderate to high doses causes an increase in total mortality." | 8.79 | Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. ( Furberg, CD; Meyer, JV; Psaty, BM, 1995) |
| " Therefore, this study was aimed to investigate the effects of mebudipine on myocardial arrhythmias and tissue injury induced by ischemia/reperfusion injury in isolated rat hearts." | 7.83 | The effects of mebudipine on myocardial arrhythmia induced by ischemia-reperfusion injury in isolated rat heart. ( Badalzadeh, R; Ghiasi, A; Ghiasi, R; Majidinia, M; Mohammadi, M; Yousefi, B, 2016) |
| " The purpose of the present study was to evaluate the effects of nifedipine, a calcium channel blocker, on epileptic seizures and on reperfusion arrhythmias in rats prone to audiogenic epileptic seizures (Wistar audiogenic rats, WAR) and in normal Wistar rats (N = 6/group)." | 7.78 | Anticonvulsant and antiarrhythmic effects of nifedipine in rats prone to audiogenic seizures. ( Almeida, AP; Damasceno, DD; Doretto, MC; Ferreira, AJ, 2012) |
| "The effects of verapamil and nifedipine on cellular mechanisms of arrhythmia were examined in isolated canine Purkinje fiber-papillary muscles." | 7.68 | Effects of verapamil and nifedipine on mechanisms of arrhythmia in an in vitro model of ischemia and reperfusion. ( Ferrier, GR; Mohabir, R, 1991) |
| "Intravenous picrotoxin injection has been established as a model of producing arrhythmias, mainly through enhanced central sympathetic outflow." | 7.67 | Effects of calcium-channel blockers on picrotoxin-induced centrogenic arrhythmias in cats. ( Chai, CY; Chiang, BN; Deng, JF; Hou, ZY; Kuo, JS; Liu, RH, 1988) |
| " Nifedipine and DHM9 (carboxymethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate) were studied for their effects on arrhythmias resulting from regional myocardial ischaemia in conscious rats, and for their effects on left ventricular developed pressure in vitro." | 7.67 | The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9. ( Curtis, MJ; Walker, MJ, 1988) |
| "The antiarrhythmic activity of the calcium entry blockers, verapamil, nifedipine and prenylamine, was assessed against arrhythmias occurring during 20 min of acute occlusion, or upon rapid reperfusion of the left anterior descending coronary artery (LAD) in anesthetized pigs." | 7.67 | Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. ( Bergey, JL; McCallum, JD; Nocella, K; Wendt, RL, 1984) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 7.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "m-Nisoldipine iv 3, 5 and 10 micrograms/kg before coronary artery ligation markedly reduced the early ischemic arrhythmia in conscious rats." | 7.67 | [Effects of m-nisoldipine on ischemic arrhythmia in conscious rats]. ( An, RH; Fu, SX; Li, YS, 1989) |
| "To examine whether nicardipine, a dihydropyridine derivative, limits size of myocardial infarction, and to compare the protective effects of nicardipine administered before and early and late after coronary artery occlusion, 99mTc-labeled albumin microspheres were injected into the left atrium during 5 min temporary coronary artery occlusion to determine the extent of the hypoperfused zone (the area at risk)." | 7.67 | Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Iida, N; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1986) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 6.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "To test the hypothesis that such arrhythmias may be mediated by sarcolemmal stretch-activated channels, we attempted to inhibit stretch-induced arrhythmias with gadolinium (Gd3+), a potent stretch-activated channel blocker." | 5.28 | Dose-dependent inhibition of stretch-induced arrhythmias by gadolinium in isolated canine ventricles. Evidence for a unique mode of antiarrhythmic action. ( Borganelli, M; Hansen, DE; Stacy, GP; Taylor, LK, 1991) |
| "The number of reperfusion arrhythmias was also significantly lower in the treated animals." | 5.27 | Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function. ( ten Cate, FJ; Verdouw, PD; Wolffenbuttel, BH, 1983) |
| "Arrhythmias were induced in isolated rat atrial muscle preparations by increasing the calcium concentration of the Ringer solution, while the potassium concentration was kept low." | 5.26 | Calcium, nifedipine and arrhythmias in isolated rat atria. ( Bjerve, KS; Landmark, K; Refsum, H, 1979) |
| "A randomized study was performed on 70 patients undergoing elective coronary bypass grafting to examine whether the combined infusion of the calcium channel blocker nifedipine (10 micrograms/kg per hour) and the beta 1-blocker metopropol (12 micrograms/kg per hour, n = 34) reduces the prevalence of perioperative myocardial ischemia and arrhythmias." | 5.08 | Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass grafting. ( Binder, TM; Podesser, BK; Schwarzacher, S; Seitelberger, R; Wolner, E; Zwoelfer, W, 1995) |
| "A single-blind trial was conducted under the direction of the Shanghai Institute of Hypertension in 1632 subjects aged 60-79 years alternatively allocated to either nifedipine or placebo after a 4-week placebo run-in period between 1987 and 1990 with mean follow-up of 30 months." | 5.08 | Shanghai trial of nifedipine in the elderly (STONE). ( Ghadirian, P; Gong, L; Hamet, P; Kong, D; LeLorier, J; Pagé, V; Zhang, W; Zhu, J; Zhu, Y, 1996) |
| "A randomized study was performed on 70 patients undergoing elective coronary bypass surgery to examine whether the combined, perioperative, 24-hour infusion of the calcium-channel blocker nifedipine (10 micrograms/kg/h) and the beta 1-blocker metoprolol (12 micrograms/kg/h) reduces the incidence of perioperative myocardial ischemia and arrhythmias (group NM, n = 34)." | 5.07 | Combined perioperative infusion of nifedipine and metoprolol provides antiischemic and antiarrhythmic protection in patients undergoing elective aortocoronary bypass surgery. ( Binder, TM; Huber, S; Peschl, F; Podesser, B; Schwarzacher, S; Seitelberger, R; Spatt, J; Zwölfer, W, 1993) |
| "A randomised study was performed on 70 patients undergoing elective coronary by-pass procedure to examine whether the combined, perioperative, 24-hour infusion of nifedipine and metoprolol reduces the incidence of perioperative myocardial ischemia and arrhythmias." | 5.07 | Perioperative infusion of nifedipine and metoprolol provides antiischemic and antiarrhythmic protection in patients undergoing elective aortocoronary by-pass surgery. ( Binder, T; Huber, S; Peschl, F; Podesser, B; Schwarzacher, S; Seitelberger, R; Spatt, J; Wolner, E; Zwölfer, W, 1994) |
| "In a double-blind placebo-controlled trial to study the effect of nifedipine on ventricular arrhythmias among patients with acute myocardial infarction, 434 patients with suspected myocardial infarction were randomized within 6 h from the onset of chest pain to treatment with nifedipine (p = 217) or placebo (p = 217)." | 5.06 | Effect of nifedipine on arrhythmias in the acute phase of myocardial infarction. ( Adgey, AA; MacKenzie, G; Walker, LJ, 1988) |
| "In patients with coronary disease, the use of short-acting nifedipine in moderate to high doses causes an increase in total mortality." | 4.79 | Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. ( Furberg, CD; Meyer, JV; Psaty, BM, 1995) |
| " In experimental animals, verapamil has been shown to reduce vulnerability to ventricular fibrillation during sympathetic stimulation and to prevent spontaneous fibrillation during both myocardial ischaemia and reperfusion." | 4.77 | Mechanisms involved in reperfusion arrhythmias. ( Hagestad, EL; Verrier, RL, 1986) |
| "Nifedipine immediate release (IR) is a short-acting dihydropyridine calcium channel blocker historically used for hypertensive crisis, but its use has decreased because of reports of adverse reactions such as myocardial infarction (MI), arrhythmias, and stroke." | 3.83 | Safety of Immediate-Release Nifedipine. ( Benken, ST; Means, L; Tesoro, EP, 2016) |
| " Therefore, this study was aimed to investigate the effects of mebudipine on myocardial arrhythmias and tissue injury induced by ischemia/reperfusion injury in isolated rat hearts." | 3.83 | The effects of mebudipine on myocardial arrhythmia induced by ischemia-reperfusion injury in isolated rat heart. ( Badalzadeh, R; Ghiasi, A; Ghiasi, R; Majidinia, M; Mohammadi, M; Yousefi, B, 2016) |
| " We therefore decided to compare the influence of oral and intravenous administration of furnidipine, nifedipine, nitrendipine and nimodipine to examine their effects on hemodynamics and arrhythmias." | 3.78 | Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine. ( Krzemiński, TF; Mitręga, KA; Porc, M; Varghese, B, 2012) |
| " The purpose of the present study was to evaluate the effects of nifedipine, a calcium channel blocker, on epileptic seizures and on reperfusion arrhythmias in rats prone to audiogenic epileptic seizures (Wistar audiogenic rats, WAR) and in normal Wistar rats (N = 6/group)." | 3.78 | Anticonvulsant and antiarrhythmic effects of nifedipine in rats prone to audiogenic seizures. ( Almeida, AP; Damasceno, DD; Doretto, MC; Ferreira, AJ, 2012) |
| "Verapamil, which has profound electrophysiologic effects on the slow inward current, is emerging as a valuable antiarrhythmic agent." | 3.75 | Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. ( Antman, EM; Braunwald, E; Muller, JE; Stone, PH, 1980) |
| "Ketanserin and calcium antagonists are frequently used for the treatment of arterial hypertension in the elderly." | 3.68 | [Cardiac interactions between ketanserin and the calcium antagonist nifedipine]. ( Alberio, L; Beretta-Piccoli, C; Koch, P; Tanzi, F; Zehender, M, 1992) |
| "Hypotension, sinus node suppression, and dysrhythmias often occur with calcium channel blocker overdoses, but atrioventricular nodal block occurs more often with verapamil (chi 2 test, P < ." | 3.68 | A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. ( Borys, D; Ramoska, EA; Spiller, HA; Winter, M, 1993) |
| "The effects of verapamil and nifedipine on cellular mechanisms of arrhythmia were examined in isolated canine Purkinje fiber-papillary muscles." | 3.68 | Effects of verapamil and nifedipine on mechanisms of arrhythmia in an in vitro model of ischemia and reperfusion. ( Ferrier, GR; Mohabir, R, 1991) |
| " Nifedipine and DHM9 (carboxymethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate) were studied for their effects on arrhythmias resulting from regional myocardial ischaemia in conscious rats, and for their effects on left ventricular developed pressure in vitro." | 3.67 | The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9. ( Curtis, MJ; Walker, MJ, 1988) |
| "The effects of three calcium antagonists (diltiazem, verapamil, and nifedipine) on reperfusion-induced arrhythmias were compared in a conscious rat preparation with coronary artery occlusion and implanted electrocardiogram limb electrodes." | 3.67 | Reperfusion-induced arrhythmias in the conscious rat: a comparative study with three calcium antagonists. ( Braimbridge, MV; Hearse, DJ; Kinoshita, K; Manning, AS; Mitani, A, 1989) |
| "m-Nisoldipine iv 3, 5 and 10 micrograms/kg before coronary artery ligation markedly reduced the early ischemic arrhythmia in conscious rats." | 3.67 | [Effects of m-nisoldipine on ischemic arrhythmia in conscious rats]. ( An, RH; Fu, SX; Li, YS, 1989) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 3.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "Intravenous picrotoxin injection has been established as a model of producing arrhythmias, mainly through enhanced central sympathetic outflow." | 3.67 | Effects of calcium-channel blockers on picrotoxin-induced centrogenic arrhythmias in cats. ( Chai, CY; Chiang, BN; Deng, JF; Hou, ZY; Kuo, JS; Liu, RH, 1988) |
| "The antiarrhythmic activity of the calcium entry blockers, verapamil, nifedipine and prenylamine, was assessed against arrhythmias occurring during 20 min of acute occlusion, or upon rapid reperfusion of the left anterior descending coronary artery (LAD) in anesthetized pigs." | 3.67 | Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. ( Bergey, JL; McCallum, JD; Nocella, K; Wendt, RL, 1984) |
| "To examine whether nicardipine, a dihydropyridine derivative, limits size of myocardial infarction, and to compare the protective effects of nicardipine administered before and early and late after coronary artery occlusion, 99mTc-labeled albumin microspheres were injected into the left atrium during 5 min temporary coronary artery occlusion to determine the extent of the hypoperfused zone (the area at risk)." | 3.67 | Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Iida, N; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1986) |
| "The ability of the two calcium-antagonists Verapamil and Nifedipine to reduce ventricular electrical instability following acute transient coronary artery occlusion and release and to prevent ventricular arrhythmias, particularly fibrillation, was evaluated on a total of 25 anaesthetized and artificially ventilated dogs." | 3.67 | [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion]. ( Bender, F; Brisse, B; Gülker, H; Thale, J, 1984) |
| "The intravenous administration of either nifedipine (in doses of 5-50 microgram/kg), or nisoldipine (5-1000 microgram/kg) markedly reduced, or abolished, the serious ventricular arrhythmias (tachycardia and fibrillation) that result from acute coronary artery artery ligation in pentobarbitone-anaesthetized rats." | 3.66 | Calcium antagonists prevent early post-infarction ventricular fibrillation. ( Fagbemi, O; Parratt, JR, 1981) |
| " During hospitalization all patients were treated with calcium antagonists (Nifedipine 10/20 mg every six hours) and/or nitrates (2% nitroglycerin ointment 2 inches every six/four hours) with one death (occurring after coronary arteriography) and eleven non-fatal myocardial infarctions." | 3.66 | [Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients]. ( Ardissino, D; Bobba, P; Bramucci, E; Casali, PM; De Servi, S; Falcone, C; Martinelli, L; Minzioni, G; Mussini, A; Specchia, G; Viganò, M, 1980) |
| "In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62." | 2.67 | [Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure]. ( Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K, 1990) |
| "The incidence of ischaemia and cardiac arrhythmias was significantly higher in the placebo group on the post-operative ECG." | 2.67 | Cardioprotection by nifedipine cardioplegia during coronary artery surgery. ( Haider, W; Laczkovics, A; Moritz, A; Trubel, W; Zwoelfer, W, 1994) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 2.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "This article outlines the risks of sudden cardiac death conferred by hypertension and left ventricular hypertrophy, presents the results of experiments using an animal model of myocardial stretch and discusses some possible mechanisms underlying stretch-induced arrhythmias which may be important in hypertensive patients." | 2.41 | Experimental studies on myocardial stretch and ventricular arrhythmia in hypertrophied and non-hypertrophied hearts. ( Dalton, GR; Evans, SJ; Levi, AJ, 2000) |
| " The reported adverse effect profile for each of these drugs varies, but tends to hold true to drug class and are typified by the adverse reactions reported for nifedipine and amlodipine (dihydropyridines), diltiazem (benzothiazepines) and verapamil (phenylalkylamines)." | 2.39 | A comparative review of the adverse effects of calcium antagonists. ( Dougall, HT; McLay, J, 1996) |
| "Treatment with nifedipine can safely be combined with administration of a beta receptor blocking agent." | 2.36 | Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. ( Henry, PD, 1980) |
| "To better understand LQTS arrhythmias, we performed current-clamp and intracellular calcium ([Ca(2+)]i) measurements on cardiomyocytes differentiated from patient-derived induced pluripotent stem cells (iPS-CM)." | 1.40 | Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia. ( Aalto-Setälä, K; Baba, S; Balijepalli, S; Conklin, BR; Fu, CC; Hayashi, Y; Healy, KE; Hua, EA; January, CT; Kamp, TJ; Lizarraga, P; Makielski, JC; Nakamura, K; Scheinman, MM; Sears, MA; Spencer, CI; Tomoda, K; Wojciak, J; Yamanaka, S; Zhang, J, 2014) |
| "38 patients with ischemic heart disease (IHD) and sick sinus syndrome (SSS) received combined therapy with nifedipine (Corinfar-Retard) and talinolol (Cordanum)." | 1.30 | [The use of Cordanum in combination with Corinfar-Retard for the treatment of ectopic arrhythmias in the sick sinus syndrome in patients with ischemic heart disease]. ( Arsent'eva, NR; Chernova, EV; Doshchitsin, VL; Kuchinskaia, NG; Lindo, IN; Martynova, VN; Shatukhina, EIu, 1997) |
| " The rats were observed for toxic signs and survival over a period of 15 days." | 1.29 | Reversal of acute theophylline toxicity by calcium channel blockers in dogs and rats. ( Alleva, FR; Balazs, T; Joseph, X; Vick, JA; Whitehurst, VE; Zhang, J, 1996) |
| " The mean nontoxic dose was 320 mg, whereas the mean toxic ingestion was 3." | 1.28 | Calcium channel blocker toxicity. ( Myers, A; Ramoska, EA; Spiller, HA, 1990) |
| "Pretreatment with nifedipine or a reduction of external calcium, that either maintained or further enhanced the forskolin-induced increase in the cAMP level, abolished the forskolin-induced arrhythmia." | 1.28 | Arrhythmogenic effect of forskolin in the isolated perfused rat heart: influence of nifedipine or reduction of external calcium [corrected]. ( Huang, XD; Wong, TM, 1989) |
| "Larger doses of BAY K 8644 produced arrhythmias only in 12 months old rats, which was not totally abolished by nitroglycerine pretreatment." | 1.28 | Enhancement in myocardial inotropic response to BAY K 8644 with advancing age. ( Khatter, JC; Navaratnam, S, 1992) |
| "To test the hypothesis that such arrhythmias may be mediated by sarcolemmal stretch-activated channels, we attempted to inhibit stretch-induced arrhythmias with gadolinium (Gd3+), a potent stretch-activated channel blocker." | 1.28 | Dose-dependent inhibition of stretch-induced arrhythmias by gadolinium in isolated canine ventricles. Evidence for a unique mode of antiarrhythmic action. ( Borganelli, M; Hansen, DE; Stacy, GP; Taylor, LK, 1991) |
| "They also have great potential for the treatment of hypertension, cerebrovascular disorders, and Raynaud's phenomenon." | 1.27 | Calcium channel blocking drugs. Part II: Clinical applications. ( Brill, DM; Fozzard, HA, 1985) |
| "The number of reperfusion arrhythmias was also significantly lower in the treated animals." | 1.27 | Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function. ( ten Cate, FJ; Verdouw, PD; Wolffenbuttel, BH, 1983) |
| "Twenty-six patients had no ventricular arrhythmias in 633 ischemic attacks; 16 patients had ventricular arrhythmias in 116/586 ischemic attacks." | 1.27 | [Characterization and therapy of ventricular arrhythmias due to transient myocardial ischemic attacks in variant angina]. ( Dini, P; Prati, PL; Rocca, P; Turitto, G; Vicari, M; Zanchi, E, 1984) |
| "Verapamil was more effective than diltiazem." | 1.27 | Comparison of the effects of calcium channel blockers and antiarrhythmic drugs on digitalis-induced oscillatory afterpotentials on canine Purkinje fiber. ( Endou, K; Sato, T; Yamamoto, H, 1987) |
| "Oral felodipine (10mg) was given to 11 patients undergoing routine invasive electrophysiological studies." | 1.27 | Electrophysiological effects of felodipine. ( Been, M; Hillis, WS; Macfarlane, PW, 1985) |
| "Arrhythmias were induced in isolated rat atrial muscle preparations by increasing the calcium concentration of the Ringer solution, while the potassium concentration was kept low." | 1.26 | Calcium, nifedipine and arrhythmias in isolated rat atria. ( Bjerve, KS; Landmark, K; Refsum, H, 1979) |
| "Nifedipine was dramatically effective in suppressing repeatedly occurring ventricular fibrillation." | 1.26 | Variant form of angina pectoris: its clinical features and treatment. The 185th Luis Guerrero Memorial Lecture given at the 6th Paul Dudley White Session, University of Santo Tomas, Manila, The Philippines, January 24, 1979. ( Kimura, E, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 105 (66.88) | 18.7374 |
| 1990's | 24 (15.29) | 18.2507 |
| 2000's | 15 (9.55) | 29.6817 |
| 2010's | 12 (7.64) | 24.3611 |
| 2020's | 1 (0.64) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, L | 1 |
| Sun, H | 1 |
| Vivier, D | 1 |
| Bennis, K | 1 |
| Lesage, F | 1 |
| Ducki, S | 1 |
| Bai, S | 1 |
| Pei, J | 1 |
| Chen, K | 1 |
| Zhao, Y | 1 |
| Cao, H | 1 |
| Tian, L | 1 |
| Ma, Y | 1 |
| Dong, H | 1 |
| Doris, U | 1 |
| Kharche, S | 1 |
| Petkova, M | 1 |
| Borbas, B | 1 |
| Logantha, SJRJ | 1 |
| Fedorenko, O | 1 |
| Maczewski, M | 1 |
| Mackiewicz, U | 1 |
| Zhang, Y | 6 |
| Chahal, A | 1 |
| D'Souza, A | 1 |
| Atkinson, AJ | 1 |
| Dobrzynski, H | 1 |
| Yanni, J | 1 |
| Spencer, CI | 1 |
| Baba, S | 1 |
| Nakamura, K | 1 |
| Hua, EA | 1 |
| Sears, MA | 1 |
| Fu, CC | 1 |
| Zhang, J | 2 |
| Balijepalli, S | 1 |
| Tomoda, K | 1 |
| Hayashi, Y | 1 |
| Lizarraga, P | 1 |
| Wojciak, J | 1 |
| Scheinman, MM | 1 |
| Aalto-Setälä, K | 1 |
| Makielski, JC | 1 |
| January, CT | 1 |
| Healy, KE | 1 |
| Kamp, TJ | 1 |
| Yamanaka, S | 1 |
| Conklin, BR | 1 |
| Means, L | 1 |
| Benken, ST | 1 |
| Tesoro, EP | 1 |
| Ghiasi, R | 1 |
| Mohammadi, M | 1 |
| Majidinia, M | 1 |
| Yousefi, B | 1 |
| Ghiasi, A | 1 |
| Badalzadeh, R | 1 |
| Ghais, NS | 1 |
| Grace, AA | 7 |
| Huang, CL | 7 |
| Schwiening, C | 2 |
| Killeen, MJ | 5 |
| Ma, A | 1 |
| Lei, M | 1 |
| Fraser, JA | 1 |
| Bozbaş, SS | 1 |
| Bozbaş, H | 1 |
| Atar, A | 1 |
| Ulubay, G | 1 |
| Oner Eyüboğlu, F | 1 |
| Chen, F | 1 |
| De Diego, C | 1 |
| Chang, MG | 1 |
| McHarg, JL | 1 |
| John, S | 1 |
| Klitzner, TS | 1 |
| Weiss, JN | 2 |
| Madhvani, RV | 1 |
| Xie, Y | 1 |
| Pantazis, A | 1 |
| Garfinkel, A | 1 |
| Qu, Z | 1 |
| Olcese, R | 1 |
| Jonsson, MK | 1 |
| Vos, MA | 1 |
| Mirams, GR | 1 |
| Duker, G | 1 |
| Sartipy, P | 1 |
| de Boer, TP | 1 |
| van Veen, TA | 1 |
| Mitręga, KA | 1 |
| Varghese, B | 1 |
| Porc, M | 1 |
| Krzemiński, TF | 1 |
| Damasceno, DD | 1 |
| Ferreira, AJ | 1 |
| Doretto, MC | 1 |
| Almeida, AP | 1 |
| Cheung, BM | 1 |
| Kumana, CR | 1 |
| Balasubramaniam, R | 2 |
| Saumarez, RC | 1 |
| Vandenberg, JI | 1 |
| Verkerk, AO | 1 |
| van Ginneken, AC | 1 |
| Berecki, G | 1 |
| den Ruijter, HM | 1 |
| Schumacher, CA | 1 |
| Veldkamp, MW | 1 |
| Baartscheer, A | 1 |
| Casini, S | 1 |
| Opthof, T | 1 |
| Hovenier, R | 1 |
| Fiolet, JW | 1 |
| Zock, PL | 1 |
| Coronel, R | 1 |
| Thomas, G | 3 |
| Gurung, IS | 3 |
| Hakim, P | 2 |
| Goddard, CA | 2 |
| Mahaut-Smith, MP | 1 |
| Colledge, WH | 1 |
| Tian, XL | 1 |
| Cheng, Y | 1 |
| Zhang, T | 1 |
| Liao, ML | 1 |
| Yong, SL | 1 |
| Wang, QK | 1 |
| Saponara, S | 1 |
| Ferrara, A | 1 |
| Gorelli, B | 1 |
| Shah, A | 1 |
| Kawase, M | 1 |
| Motohashi, N | 1 |
| Molnar, J | 1 |
| Sgaragli, G | 1 |
| Fusi, F | 1 |
| Stokoe, KS | 1 |
| Zaniboni, M | 1 |
| Cacciani, F | 1 |
| Salvarani, N | 1 |
| Stone, KS | 1 |
| Scordo, KA | 1 |
| Opie, LH | 3 |
| Karlsberg, RP | 2 |
| Krikler, DM | 2 |
| Rowland, E | 2 |
| Vanhaleweyk, GL | 1 |
| Serruys, PW | 1 |
| Hugenholtz, PG | 1 |
| Ellrodt, AG | 1 |
| Singh, BN | 2 |
| Ellrodt, G | 1 |
| Chew, CY | 1 |
| Henry, PD | 1 |
| Antman, EM | 1 |
| Stone, PH | 1 |
| Muller, JE | 1 |
| Braunwald, E | 2 |
| Horwitz, DL | 1 |
| Ribeiro, LG | 3 |
| Brandon, TA | 3 |
| Debauche, TL | 2 |
| Maroko, PR | 3 |
| Miller, RR | 3 |
| Bianchi, CP | 1 |
| Gould, RJ | 1 |
| Murphy, KM | 1 |
| Reynolds, IJ | 1 |
| Snyder, SH | 1 |
| Covinsky, JO | 1 |
| Hamburger, SC | 1 |
| Tullio, D | 1 |
| Valerio, A | 1 |
| D'Agostino, F | 1 |
| Pine, RM | 1 |
| Amoroso, A | 1 |
| Lanciotti, G | 1 |
| Mammarella, A | 1 |
| Moenning, SP | 1 |
| Hope, RR | 1 |
| Lazzara, R | 1 |
| Moe, BH | 1 |
| Gülker, H | 2 |
| Thale, J | 1 |
| Brisse, B | 1 |
| Bender, F | 2 |
| Turitto, G | 1 |
| Dini, P | 1 |
| Rocca, P | 1 |
| Vicari, M | 1 |
| Zanchi, E | 1 |
| Prati, PL | 1 |
| Hicks, GL | 1 |
| Salley, RK | 1 |
| DeWeese, JA | 1 |
| Verdouw, PD | 1 |
| Wolffenbuttel, BH | 1 |
| ten Cate, FJ | 1 |
| Parratt, JR | 3 |
| Coker, SJ | 1 |
| Galle, JS | 1 |
| Bergey, JL | 2 |
| Wendt, RL | 1 |
| Nocella, K | 2 |
| McCallum, JD | 2 |
| Reves, JG | 1 |
| Kissin, I | 1 |
| Lell, WA | 1 |
| Tosone, S | 1 |
| Casali, PM | 1 |
| De Servi, S | 1 |
| Ardissino, D | 1 |
| Martinelli, L | 1 |
| Mussini, A | 1 |
| Bramucci, E | 1 |
| Falcone, C | 1 |
| Minzioni, G | 1 |
| Viganò, M | 1 |
| Specchia, G | 1 |
| Bobba, P | 1 |
| Nobile-Orazio, E | 1 |
| Sterzi, R | 1 |
| Dipalma, JR | 1 |
| Kimura, E | 1 |
| Zsotér, TT | 1 |
| Lehmann, HU | 1 |
| Hochrein, H | 1 |
| Check, WA | 1 |
| McKenna, WJ | 1 |
| Goodwin, JF | 1 |
| Schwartz, A | 1 |
| Sheehan, FH | 1 |
| Epstein, SE | 1 |
| Grayson, HA | 1 |
| Kennedy, JD | 1 |
| De Bauche, TL | 1 |
| Diewitz, M | 1 |
| Fagbemi, O | 2 |
| Lancelin, B | 1 |
| Blanchard, D | 1 |
| Aziza, JP | 1 |
| Guermonprez, JL | 1 |
| Maurice, P | 1 |
| Spracklen, FH | 1 |
| Lazarus, LH | 1 |
| Podesser, BK | 1 |
| Schwarzacher, S | 3 |
| Zwoelfer, W | 2 |
| Binder, TM | 2 |
| Wolner, E | 2 |
| Seitelberger, R | 3 |
| Stoudemire, A | 1 |
| Messerli, FH | 1 |
| Furberg, CD | 1 |
| Psaty, BM | 1 |
| Meyer, JV | 1 |
| Podesser, B | 2 |
| Zwölfer, W | 2 |
| Binder, T | 1 |
| Spatt, J | 2 |
| Peschl, F | 2 |
| Huber, S | 2 |
| Kocemba, J | 1 |
| Kawecka-Jaszcz, K | 1 |
| Grodzicki, T | 1 |
| Czarnecka, D | 1 |
| Gryglewska, B | 1 |
| Skalska, A | 1 |
| Trubel, W | 1 |
| Moritz, A | 1 |
| Laczkovics, A | 1 |
| Haider, W | 1 |
| Ramoska, EA | 2 |
| Spiller, HA | 2 |
| Winter, M | 1 |
| Borys, D | 1 |
| Whitehurst, VE | 1 |
| Joseph, X | 1 |
| Vick, JA | 1 |
| Alleva, FR | 1 |
| Balazs, T | 1 |
| Dougall, HT | 1 |
| McLay, J | 1 |
| Gong, L | 1 |
| Zhang, W | 1 |
| Zhu, Y | 1 |
| Zhu, J | 1 |
| Kong, D | 1 |
| Pagé, V | 1 |
| Ghadirian, P | 1 |
| LeLorier, J | 1 |
| Hamet, P | 1 |
| Doshchitsin, VL | 1 |
| Martynova, VN | 1 |
| Lindo, IN | 1 |
| Kuchinskaia, NG | 1 |
| Chernova, EV | 1 |
| Shatukhina, EIu | 1 |
| Arsent'eva, NR | 1 |
| Bhattacharyya, TK | 1 |
| Mukhopadhyay, M | 1 |
| Debnath, PK | 1 |
| Aimond, F | 1 |
| Alvarez, JL | 1 |
| Rauzier, JM | 1 |
| Lorente, P | 1 |
| Vassort, G | 1 |
| Evans, SJ | 1 |
| Dalton, GR | 1 |
| Levi, AJ | 1 |
| Porpiglia, F | 1 |
| Destefanis, P | 1 |
| Fiori, C | 1 |
| Fontana, D | 1 |
| Saeki, K | 1 |
| Obi, I | 1 |
| Ogiku, N | 1 |
| Shigekawa, M | 1 |
| Imagawa, T | 1 |
| Matsumoto, T | 1 |
| Strano, A | 1 |
| Novo, S | 1 |
| Johansson, BW | 1 |
| Furlanello, F | 2 |
| Disertori, M | 2 |
| Vergara, G | 1 |
| Molinis, G | 2 |
| Guarnerio, M | 1 |
| Stefenelli, C | 1 |
| Evans, T | 1 |
| Krikler, D | 1 |
| Pérez-Olea, J | 1 |
| Quevedo, M | 1 |
| Mordoh, I | 1 |
| Campa, PP | 1 |
| Speca, G | 1 |
| De Curtis, G | 1 |
| Pecce, P | 1 |
| Antonini, L | 1 |
| Ledda, F | 1 |
| Piccolo, E | 1 |
| Cazzin, R | 1 |
| Trevi, GP | 1 |
| Pascotto, P | 1 |
| Totaro, G | 1 |
| Raviele, A | 1 |
| Refsum, H | 1 |
| Landmark, K | 1 |
| Bjerve, KS | 1 |
| Endo, M | 1 |
| Kanda, I | 1 |
| Hosoda, S | 1 |
| Hayashi, H | 1 |
| Hirosawa, K | 1 |
| Konno, S | 1 |
| Alberio, L | 1 |
| Beretta-Piccoli, C | 1 |
| Tanzi, F | 1 |
| Koch, P | 1 |
| Zehender, M | 1 |
| Khatter, JC | 1 |
| Navaratnam, S | 1 |
| Mareev, VIu | 1 |
| Kazeĭ, DV | 1 |
| Ageev, FT | 1 |
| Shevliagin, SA | 1 |
| Grigor'iants, RA | 1 |
| Mohabir, R | 1 |
| Ferrier, GR | 1 |
| Kawakage, M | 1 |
| Shirakura, S | 1 |
| Karasawa, A | 1 |
| Takeda, M | 1 |
| Miki, I | 1 |
| Ishii, A | 1 |
| Kubo, K | 1 |
| Hansen, DE | 1 |
| Borganelli, M | 1 |
| Stacy, GP | 1 |
| Taylor, LK | 1 |
| Bechler-Lisińska, J | 1 |
| Cholewa, M | 1 |
| Górski, L | 1 |
| Markiewicz, K | 1 |
| Myers, A | 1 |
| Brill, DM | 1 |
| Fozzard, HA | 1 |
| Yamamoto, F | 1 |
| Manning, AS | 2 |
| Crome, R | 1 |
| Braimbridge, MV | 2 |
| Hearse, DJ | 2 |
| Kojima, M | 1 |
| Sperelakis, N | 1 |
| Huang, XD | 1 |
| Wong, TM | 1 |
| Baba, A | 1 |
| Arita, M | 1 |
| Masuyama, Y | 1 |
| Hopf, R | 1 |
| Fleischer, K | 1 |
| Forster, A | 1 |
| Mohler, C | 1 |
| Schulz, PC | 1 |
| Kaltenbach, M | 1 |
| Munger, MA | 1 |
| Jarvis, RC | 1 |
| Nair, R | 1 |
| Kasmer, RJ | 1 |
| Nara, AR | 1 |
| Urbancic, A | 1 |
| Green, JA | 1 |
| Kinoshita, K | 1 |
| Mitani, A | 1 |
| An, RH | 1 |
| Fu, SX | 2 |
| Li, YS | 2 |
| Shub, C | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| Hartwell, BL | 1 |
| Mark, JB | 1 |
| Núñez Jáuregui, P | 1 |
| Thandroyen, FT | 1 |
| Flint, NS | 1 |
| Worthington, MG | 1 |
| Kowalchuk, GJ | 1 |
| Nesto, RW | 1 |
| Psychoyos, S | 1 |
| Bax, M | 1 |
| Atkins, C | 1 |
| Walker, LJ | 1 |
| MacKenzie, G | 1 |
| Adgey, AA | 1 |
| Wells, DG | 1 |
| Zelcer, J | 1 |
| Treadrae, C | 1 |
| Donegani, E | 1 |
| De Paulis, R | 1 |
| di Summa, M | 1 |
| Poletti, GA | 1 |
| Ottino, GM | 1 |
| Matani, A | 1 |
| Bobbio, M | 1 |
| Morea, M | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Nahas, G | 1 |
| Trouvé, R | 1 |
| Demus, JR | 1 |
| von Sitbon, M | 1 |
| Chari, P | 1 |
| Katariya, RN | 1 |
| Venkataraman, RK | 1 |
| Trikha, A | 1 |
| Curtis, MJ | 2 |
| Walker, MJ | 2 |
| Li, YL | 1 |
| Vatner, SF | 1 |
| Patrick, TA | 1 |
| Knight, DR | 1 |
| Manders, WT | 1 |
| Fallon, JT | 1 |
| Hou, ZY | 2 |
| Liu, RH | 2 |
| Deng, JF | 2 |
| Chiang, BN | 2 |
| Chai, CY | 1 |
| Kuo, JS | 2 |
| Endou, K | 1 |
| Yamamoto, H | 1 |
| Sato, T | 1 |
| Burgess, CD | 1 |
| Larach, DR | 1 |
| Zelis, R | 1 |
| Verrier, RL | 1 |
| Hagestad, EL | 1 |
| Lauterburg, BH | 1 |
| Szekeres, L | 1 |
| Udvary, E | 1 |
| Végh, A | 1 |
| Schwartz, PJ | 1 |
| Vanoli, E | 1 |
| Endo, T | 1 |
| Nejima, J | 1 |
| Fujita, S | 1 |
| Kiuchi, K | 1 |
| Iida, N | 1 |
| Kikuchi, K | 1 |
| Hayakawa, H | 1 |
| Okumura, H | 1 |
| Kaur, AH | 1 |
| Singh, M | 1 |
| Singh, J | 1 |
| Ishikawa, M | 1 |
| Yokota, N | 1 |
| Sawazaki, A | 1 |
| Kashiro, S | 1 |
| Hirata, S | 1 |
| Okada, M | 1 |
| Ishikawa, K | 1 |
| Lui, PW | 1 |
| Lee, TY | 1 |
| Liu, WS | 1 |
| Chan, KH | 1 |
| Wu, KS | 1 |
| Laio, KT | 1 |
| Kenny, J | 1 |
| du Toit, HJ | 1 |
| Weich, HF | 1 |
| Weymar, HW | 1 |
| Przybojewski, JZ | 1 |
| Been, M | 2 |
| Macfarlane, PW | 1 |
| Hillis, WS | 2 |
| Jones, CR | 1 |
| Rae, AP | 1 |
| de Vane, PJ | 1 |
| Jamieson, RR | 1 |
| Hornung, RS | 1 |
| Johnston, KM | 1 |
| Macleod, BA | 1 |
29 reviews available for nifedipine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc | 2016 |
Understanding the calcium channel blockers.
Topics: Action Potentials; Angina Pectoris; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Calcium; Calciu | 1984 |
Clinical value of calcium antagonists in treatment of cardiovascular disorders.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calciu | 1983 |
Anti-anginal, electrophysiologic and hemodynamic effects of combined beta-blocker/calcium antagonist therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Drug T | 1983 |
Clinical applications of slow channel blocking compounds.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Platelets; Blood Vessels; Calcium | 1983 |
Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Benzazepines; Calcium; Car | 1980 |
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel B | 1980 |
Mechanism of action of calcium-channel-blocking agents.
Topics: Action Potentials; Angina Pectoris; Arrhythmias, Cardiac; Blood Vessels; Calcium; Calcium Channel Bl | 1982 |
Clinical pharmacology of calcium entry blockers.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Diltiazem; Humans; Ion Cha | 1983 |
Slow channel blockers.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Cons | 1983 |
[Calcium antagonists in cardiology].
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Coronary Disease; Dilt | 1983 |
Calcium-channel blocking agents: current indications and potential uses.
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Drug Interactions; Humans; Nifedipine; Ve | 1984 |
[Calcium antagonists. Properties and current indications].
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiaze | 1984 |
Digitalis toxicity: a review of the literature.
Topics: Absorption; Arrhythmias, Cardiac; Digitalis Glycosides; Digoxin; Heart; Humans; Kinetics; Male; Nife | 1984 |
The clinical uses of calcium antagonists.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel B | 1982 |
Calcium entry blockers: uses and implications for anesthesiologists.
Topics: Anesthesia, General; Animals; Arrhythmias, Cardiac; Biotransformation; Calcium Channel Blockers; Cor | 1982 |
Calcium antagonists.
Topics: Action Potentials; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Bronchial Spasm; | 1980 |
[Indications for use of calcium antagonists].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiotonic Agents; Coronary Disease | 1980 |
The natural history of hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Humans; Nifedipine; P | 1981 |
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Confidence Intervals; Coronary Dise | 1995 |
A comparative review of the adverse effects of calcium antagonists.
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular System; Endocrine System Diseases; Ga | 1996 |
Experimental studies on myocardial stretch and ventricular arrhythmia in hypertrophied and non-hypertrophied hearts.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Cardiotonic Agents; Death, Sudden, | 2000 |
[Calcium antagonists in cardiology].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Coronary Disease; Human | 1978 |
Clinical aspects of Ca-blocking agents.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium; Coronary Disease; Cricetinae; Humans; Hyper | 1978 |
[Electrophysiological effects of calcium-antagonists and their use in arrhythmia].
Topics: Arrhythmias, Cardiac; Atrioventricular Node; Calcium; Heart Rate; Humans; Nifedipine; Pyridines; Sin | 1978 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel B | 1986 |
Mechanisms involved in reperfusion arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Dil | 1986 |
Calcium channel blocking agents and the heart.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Vasospasm; Digoxin; Diltia | 1985 |
18 trials available for nifedipine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Comparative effects of losartan and nifedipine therapy on exercise capacity, Doppler echocardiographic parameters and endothelin levels in patients with secondary pulmonary hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diastol | 2010 |
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel B | 1980 |
[Calcium antagonists. Properties and current indications].
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiaze | 1984 |
Calcium antagonists: long-awaited new therapy for heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium; Cardiomyopathies; Clinical Trials as T | 1981 |
[Dilzem: a new alternative to the therapy of angina pectoris and hypertension].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium Channel Blockers; Clinical Trials as To | 1981 |
Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Artery Bypass; | 1995 |
Perioperative infusion of nifedipine and metoprolol provides antiischemic and antiarrhythmic protection in patients undergoing elective aortocoronary by-pass surgery.
Topics: Arrhythmias, Cardiac; Coronary Artery Bypass; Creatine Kinase; Electrocardiography, Ambulatory; Enda | 1994 |
Cardioprotection by nifedipine cardioplegia during coronary artery surgery.
Topics: Arrhythmias, Cardiac; Bicarbonates; Calcium Chloride; Cardiac Output; Cardiac Output, Low; Cardiople | 1994 |
Combined perioperative infusion of nifedipine and metoprolol provides antiischemic and antiarrhythmic protection in patients undergoing elective aortocoronary bypass surgery.
Topics: Aged; Arrhythmias, Cardiac; Coronary Artery Bypass; Drug Therapy, Combination; Electrocardiography, | 1993 |
Shanghai trial of nifedipine in the elderly (STONE).
Topics: Aged; Arrhythmias, Cardiac; Calcium Channel Blockers; Cerebrovascular Disorders; Cohort Studies; Hum | 1996 |
Effectiveness of nifedipine and deflazacort in the management of distal ureter stones.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Calcium Channel B | 2000 |
[A prospective study on the effect of nifedipine of the cardiovascular complications in the elderly hypertensives].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cerebrovascular Disorders; Female; Humans; Hypertension | 1992 |
[Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
Topics: Arrhythmias, Cardiac; Captopril; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isos | 1992 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output | 1990 |
[Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Top | 1989 |
Effect of nifedipine on arrhythmias in the acute phase of myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiograph | 1988 |
Protection of the heart by nifedipine cardioplegia during coronary artery surgery. A clinical-haemodynamic evaluation.
Topics: Arrhythmias, Cardiac; Cardioplegic Solutions; Cardiopulmonary Bypass; Coronary Vessels; Creatine Kin | 1988 |
Effects of nifedipine on the peri-operative ECG, as determined by continuous Holter monitoring. A double-blind study.
Topics: Aged; Anesthesia, Inhalation; Arrhythmias, Cardiac; Double-Blind Method; Electrocardiography; Enflur | 1986 |
112 other studies available for nifedipine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant | 2008 |
Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cations, Divalent; Cell Di | 2021 |
A sexy approach to pacemaking: differences in function and molecular make up of the sinoatrial node.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channels; Calcium Channels, L-Type; Computer Simulation; Fema | 2019 |
Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia.
Topics: Action Potentials; Arrhythmias, Cardiac; Caffeine; Calcium; Cell Differentiation; Ether-A-Go-Go Pota | 2014 |
Safety of Immediate-Release Nifedipine.
Topics: Aged; Arrhythmias, Cardiac; Calcium Channel Blockers; Drug Compounding; Female; Follow-Up Studies; H | 2016 |
The effects of mebudipine on myocardial arrhythmia induced by ischemia-reperfusion injury in isolated rat heart.
Topics: Animals; Arrhythmias, Cardiac; Creatine Kinase; Heart; Heart Rate; In Vitro Techniques; L-Lactate De | 2016 |
Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Agonists; Calcium Channel | 2009 |
Pharmacological changes in cellular Ca2+ homeostasis parallel initiation of atrial arrhythmogenesis in murine Langendorff-perfused hearts.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Caffeine; Calcium; Calcium Channel Blockers; | 2009 |
Acute atrial arrhythmogenesis in murine hearts following enhanced extracellular Ca(2+) entry depends on intracellular Ca(2+) stores.
Topics: Aniline Compounds; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Caffeine; Calcium; Calcium | 2010 |
Atrioventricular conduction and arrhythmias at the initiation of beating in embryonic mouse hearts.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrioventricular Block; Calcium; Calcium Channel B | 2010 |
Shaping a new Ca²⁺ conductance to suppress early afterdepolarizations in cardiac myocytes.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Hydrogen Peroxi | 2011 |
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2012 |
Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine.
Topics: Administration, Intravenous; Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Car | 2012 |
Anticonvulsant and antiarrhythmic effects of nifedipine in rats prone to audiogenic seizures.
Topics: Acoustic Stimulation; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Arrhythmias, Cardiac; Diseas | 2012 |
Calcium channel blockers revisited.
Topics: Angina Pectoris; Antihypertensive Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; China; Cli | 2002 |
Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1.
Topics: Adrenergic beta-Agonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiac Pacing, A | 2003 |
Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Action Potentials; Animals; Antioxidants; Arrhythm | 2006 |
Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; | 2007 |
Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3.
Topics: Action Potentials; Aniline Compounds; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Calci | 2007 |
Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.
Topics: Animals; Arrhythmias, Cardiac; Asparagine; Cardiac Complexes, Premature; Long QT Syndrome; Mexiletin | 2007 |
3,5-dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7): a new multidrug resistance inhibitor devoid of effects on Langendorff-perfused rat heart.
Topics: Animals; Antineoplastic Agents; Arrhythmias, Cardiac; ATP Binding Cassette Transporter, Subfamily B; | 2007 |
Separation of early afterdepolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Benzylamines; Calcium; Calcium Channel Blockers; C | 2007 |
Temporal variability of repolarization in rat ventricular myocytes paced with time-varying frequencies.
Topics: 4-Aminopyridine; Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium | 2007 |
Drugs and the heart. III. Calcium antagonists.
Topics: Angina Pectoris; Aniline Compounds; Arrhythmias, Cardiac; Calcium; Cardiomegaly; Diuretics; Heart Di | 1980 |
Welcome--the calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blocker | 1981 |
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Cardiovascular Diseases; Coronary Disease; Diltiazem | 1980 |
Calcium channels in the heart.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Diltiazem; Electric Conductivity; Heart; Hypertension; Ion Ch | 1981 |
Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion. Comparative effects of verapamil and nifedipine.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulatio | 1981 |
Calcium channel blockers for cardiovascular disorders.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; | 1982 |
Calcium channel blockade: possible explanation for thioridazine's peripheral side effects.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Ejaculation; Female; Ion Channels; Male; Mu | 1984 |
On the therapeutic mechanism of Mg2+ in digitoxic arrhythmias and the role of cardiac glycosides in Mg depletion.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Cardiac Glycosides; Digitoxin; Dogs; Female; Heart; Magnesiu | 1984 |
[Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
Topics: Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Circulation; Dogs; Electrocardio | 1984 |
[Characterization and therapy of ventricular arrhythmias due to transient myocardial ischemic attacks in variant angina].
Topics: Adult; Aged; Angina Pectoris, Variant; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; | 1984 |
Calcium channel blockers: an intraoperative and postoperative trial in women.
Topics: Arrhythmias, Cardiac; Aspartate Aminotransferases; Calcium Channel Blockers; Coronary Artery Bypass; | 1984 |
Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Heart; Myocardium; Nifedipine; Propranolol; Swine; | 1983 |
Cardioprotection with calcium antagonists by suppression of early ischaemia and reperfusion-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Coronary Disease; Disease Models, | 1983 |
Clinical use of calcium channel blockers.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Drug Therapy, Combinatio | 1983 |
Calcium channel blocking agents. Council on scientific affairs.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Asthma; Calcium Channel Blockers; Cardiomyopathy, Hy | 1983 |
Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol.
Topics: Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Calcium Channel Blockers | 1984 |
[Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Angiography; Coronary Artery Bypass; Co | 1980 |
Cerebral ischaemia after nifedipine treatment.
Topics: Aged; Arrhythmias, Cardiac; Female; Humans; Hypertension; Ischemic Attack, Transient; Male; Nifedipi | 1981 |
Calcium channel blockers.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem | 1983 |
Variant form of angina pectoris: its clinical features and treatment. The 185th Luis Guerrero Memorial Lecture given at the 6th Paul Dudley White Session, University of Santo Tomas, Manila, The Philippines, January 24, 1979.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium; Coronary Artery Bypass; Di | 1980 |
Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Humans; Myocard | 1982 |
Effects of calcium channel blocking agents on reperfusion arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dogs; Female; He | 1982 |
Torsades de pointes and nifedipine.
Topics: Aged; Arrhythmias, Cardiac; Female; Heart Ventricles; Humans; Nifedipine; Pyridines | 1982 |
[Ventricular arrhythmias following coronary reperfusion. Comparative study of the effects of verapamil and nifedipine].
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Dogs; Female; Hemodynamics; Male; Microspheres; | 1982 |
[Effect of nifedipine on the ventricular diastolic stimulation threshold of the human heart].
Topics: Arrhythmias, Cardiac; Electric Stimulation; Female; Heart; Humans; Male; Middle Aged; Nifedipine; Py | 1981 |
Antiarrhythmic evaluation of verapamil, nifedipine, perhexiline and skf 525-A in four canine models of cardiac arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Calcium; Dogs; Female; Heart | 1981 |
Suppression by orally-administered nifedipine, nisoldipine and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischaemia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; H | 1981 |
Calcium antagonists prevent early post-infarction ventricular fibrillation.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Hemodynamics; Male; Myocardial Infarction; | 1981 |
Comparative effects of verapamil and nifedipine on reactive hyperemia and ventricular arrhythmias during coronary artery reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Femal | 1980 |
[Calcium inhibitors. Current indications in cardiology].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Cardiovascular Diseases; Diltiazem; Humans; Nifedipi | 1980 |
Nifedipine for digitalis-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Nifedipine; Phenytoin; Pyridines; Strophanthins; Verapamil | 1980 |
Calcium antagonists: mechanisms of action in arrhythmias.
Topics: Action Potentials; Arrhythmias, Cardiac; Atrioventricular Node; Biological Transport, Active; Calciu | 1980 |
Cardiovascular morbidity and ECT.
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Drug Therapy, Combi | 1995 |
Nifedipine and mortality. Grave defects in the dossier.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Autonomic Nervous System; Calcium Channel Blockers; Coronary | 1995 |
Influence of long-term treatment with nifedipine on blood pressure, left ventricular mass and cardiac arrhythmias in elderly hypertensive patients.
Topics: Aged; Aged, 80 and over; Aging; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Circadian Rhyt | 1994 |
A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atropine; Calcium; Calcium Channel Blockers; Child; C | 1993 |
Reversal of acute theophylline toxicity by calcium channel blockers in dogs and rats.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bronchodilator Agents; Calcium; Calcium Channel Block | 1996 |
[The use of Cordanum in combination with Corinfar-Retard for the treatment of ectopic arrhythmias in the sick sinus syndrome in patients with ischemic heart disease].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Delayed-Action Preparations; Drug Evaluat | 1997 |
Effect of calcium-channel blocking drugs on focal ventricular arrhythmias induced by sub-epicardial epinephrine infusion in cats.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Cats; Epinephrine; Female; Heart Ventricles | 1998 |
Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animal | 1999 |
Cardioprotective effects of 9-hydroxyellipticine on ischemia and reperfusion in isolated rat heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Binding, Competitive; Calcium; CHO Cells; Cri | 2002 |
Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Atrioventricular Node; Female; Heart Conduction System; Hum | 1979 |
[Nifedipine effect upon experimental digitalis toxicity (author's transl)].
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cats; Female; Heart Rate; Lanatosides; Male; Nifedipi | 1979 |
[Effects of calcium antagonists on left ventricular systolic time intervals in patients with artificial pacemakers].
Topics: Aged; Arrhythmias, Cardiac; Calcium; Cardiac Pacing, Artificial; Female; Heart Block; Heart Failure; | 1979 |
[Electrophysiological effects of nifedipine in humans. Preliminary note].
Topics: Administration, Oral; Adult; Arrhythmias, Cardiac; Atrioventricular Node; Coronary Disease; Electroc | 1978 |
[Pharmacological assumptions in the use of calcium antagonists].
Topics: Arrhythmias, Cardiac; Calcium; Coronary Disease; Heart Diseases; Humans; Nifedipine; Pyridines; Vera | 1978 |
[Calcium antagonists in acute coronary insufficiency].
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Coronary Disease; Female | 1978 |
Calcium, nifedipine and arrhythmias in isolated rat atria.
Topics: Animals; Arrhythmias, Cardiac; Aspartate Aminotransferases; Calcium; Female; Heart Atria; Nifedipine | 1979 |
Prinzmetal's variant form of angina pectoris. Re-evaluation of mechanisms.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cineangiography; Coronary Artery Bypass; Coronary Vessels; He | 1975 |
[Cardiac interactions between ketanserin and the calcium antagonist nifedipine].
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Complexes, Premature; Drug Interactions; Drug Th | 1992 |
Enhancement in myocardial inotropic response to BAY K 8644 with advancing age.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Effects of verapamil and nifedipine on mechanisms of arrhythmia in an in vitro model of ischemia and reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Diastole; Dogs; Electrophysiology; Heart Co | 1991 |
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygena | 1991 |
Dose-dependent inhibition of stretch-induced arrhythmias by gadolinium in isolated canine ventricles. Evidence for a unique mode of antiarrhythmic action.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diastole; Dogs; Dose-Respo | 1991 |
Calcium channel blocker toxicity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Child; Child, Preschool; Delaware; | 1990 |
Calcium channel blocking drugs. Part II: Clinical applications.
Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Arrhythmias, Cardiac; Calcium Channel B | 1985 |
Calcium antagonists and myocardial protection: a comparative study of the functional, metabolic and electrical consequences of verapamil and nifedipine as additives to the St. Thomas' cardioplegic solution.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiopulmonary Bypass; Disease Models, Anim | 1985 |
Effects of calcium channel blockers on ouabain-induced oscillatory afterpotentials in organ-cultured young embryonic chick hearts.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bepridil; Calcium Channel Blockers; Chick Embryo; | 1986 |
Arrhythmogenic effect of forskolin in the isolated perfused rat heart: influence of nifedipine or reduction of external calcium [corrected].
Topics: Animals; Arrhythmias, Cardiac; Calcium; Colforsin; Cyclic AMP; Female; In Vitro Techniques; Myocardi | 1989 |
[New approach to the development of Ca antagonists].
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Humans; Hypertension; Nic | 1989 |
Elucidation of the nifedipine-quinidine interaction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Interactions; Drug Therapy, Combination; Humans; Metabolic C | 1989 |
Reperfusion-induced arrhythmias in the conscious rat: a comparative study with three calcium antagonists.
Topics: Animals; Arrhythmias, Cardiac; Consciousness; Coronary Disease; Diltiazem; Electrocardiography; Hear | 1989 |
[Effects of m-nisoldipine on ischemic arrhythmia in conscious rats].
Topics: Animals; Arrhythmias, Cardiac; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; | 1989 |
Combinations of beta-blockers and calcium channel blockers: a cause of malignant perioperative conduction disturbances?
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Corona | 1986 |
[Use of nifedipine in patients with advanced arteriosclerotic cardiopathy].
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Cardiac Output, Low; Coronary Artery Diseas | 1986 |
Arrhythmogenic action of alpha 1-adrenoceptor stimulation in normoxic rat ventricular myocardium: influence of nisoldipine, reduced extracellular Ca2+ and ryanodine.
Topics: Adrenergic alpha-Agonists; Alkaloids; Animals; Arrhythmias, Cardiac; Azepines; Calcium; Calcium Chan | 1987 |
Silent myocardial ischemia. Mechanisms and rationale for therapy.
Topics: Arrhythmias, Cardiac; Chest Pain; Coronary Disease; Heart; Humans; Nifedipine; Prognosis; Propranolo | 1989 |
Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brain.
Topics: Adenine; Adenosine; Animals; Arrhythmias, Cardiac; Brain Chemistry; Calcium Channel Blockers; Cell M | 1986 |
ECT-induced asystole from a sub-convulsive shock.
Topics: Aged; Anesthesia, Intravenous; Arrhythmias, Cardiac; Atropine; Electroconvulsive Therapy; Heart Arre | 1988 |
Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Dogs; Fem | 1987 |
A calcium-channel blocker as antidote to the cardiac effects of cocaine intoxication.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Cocaine; Dogs; Nifedipine; Nitrendipine; Ra | 1985 |
Nifedipine and surgical removal of phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Arrhythmias, Cardiac; Female; Humans; Hypertension; Intraoperative C | 1988 |
The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Electroca | 1988 |
[Prophylactic effects of m-nisoldipine and nisoldipine on reperfusion arrhythmia in hearts of rats].
Topics: Animals; Arrhythmias, Cardiac; Calcium; Fatty Acids, Nonesterified; Free Radicals; Isomerism; Male; | 1988 |
Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Cre | 1988 |
Effects of calcium-channel blockers on picrotoxin-induced centrogenic arrhythmias in cats.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Cats; Female; Heart Rate; M | 1988 |
Comparison of the effects of calcium channel blockers and antiarrhythmic drugs on digitalis-induced oscillatory afterpotentials on canine Purkinje fiber.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Digitalis; Diltiaze | 1987 |
Calcium channel antagonists--cardiovascular therapy for the eighties?
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; | 1986 |
Suppression of picrotoxin-induced cardiac arrhythmias by nifedipine in cats.
Topics: Animals; Arrhythmias, Cardiac; Cats; Female; Male; Nifedipine; Picrotoxin | 1987 |
[Clinical pharmacology of calcium antagonists].
Topics: Aging; Arrhythmias, Cardiac; Biological Availability; Calcium Channel Blockers; Diltiazem; Drug Inte | 1987 |
Nifedipine effects in severe myocardial ischaemia in the dog due to left anterior descending coronary occlusion with left circumflex coronary artery constriction.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Fe | 1987 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem | 1986 |
Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Dogs; Female; Hemodynamics; M | 1986 |
Antiarrhythmic effect of calcium slow channel blockers (verapamil, nifedipine and diltiazem) in ventricular arrhythmias induced by coronary artery occlusion in dogs.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Dogs; Female; | 1986 |
Rectal administration of perforated nifedipine capsules to maintain an effective level of longer duration.
Topics: Administration, Oral; Administration, Rectal; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Hea | 1986 |
Effects of chronic nifedipine administration on epinephrine-induced arrhythmias during isoflurane anesthesia in dogs.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Dogs; Drug Synergism; Epinephrine; Female; Halothane; Iso | 1986 |
Electrophysiological effects of felodipine.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; | 1985 |
Electrophysiological effects of felodipine in combination with metoprolol.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; | 1985 |
The actions of felodipine on arrhythmias and other responses to myocardial ischaemia in conscious rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Electrocard | 1985 |